These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 12149296

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G, Sprinz E, Kromfield M, Kalakun L, Sander E, Prolla G, Di Leone L, Gerhardt L, Mans DR.
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT.
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [Abstract] [Full Text] [Related]

  • 4. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS.
    Cancer; 2002 Jul 01; 95(1):147-54. PubMed ID: 12115328
    [Abstract] [Full Text] [Related]

  • 5. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
    Paredes J, Kahn JO, Tong WP, Feldstein ML, Lin S, Bennett JM, Metroka CE, Ratner L, Krown SE.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun 01; 9(2):138-44. PubMed ID: 7749790
    [Abstract] [Full Text] [Related]

  • 6. Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
    Sprinz E, Caldas AP, Mans DR, Cancela A, DiLeone L, Dalla Costa T, Schwartsmann G.
    Am J Clin Oncol; 2001 Apr 01; 24(2):177-84. PubMed ID: 11319295
    [Abstract] [Full Text] [Related]

  • 7. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
    Remick SC, Reddy M, Ekman K, Vyzula R, Hilstro J, Horton J.
    J Infus Chemother; 1996 Apr 01; 6(2):92-6. PubMed ID: 8809657
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME, Lachter J, Spencer D, Bezwoda WR.
    Int J Dermatol; 1995 Oct 01; 34(10):729-32. PubMed ID: 8537166
    [Abstract] [Full Text] [Related]

  • 9. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
    Autier J, Picard-Dahan C, Marinho E, Grossin M, Yeni P, Leport C, Vildé JL, Crickx B, Descamps V.
    Br J Dermatol; 2005 May 01; 152(5):1026-9. PubMed ID: 15888164
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
    Welles L, Saville MW, Lietzau J, Pluda JM, Wyvill KM, Feuerstein I, Figg WD, Lush R, Odom J, Wilson WH, Fajardo MT, Humphrey RW, Feigal E, Tuck D, Steinberg SM, Broder S, Yarchoan R.
    J Clin Oncol; 1998 Mar 01; 16(3):1112-21. PubMed ID: 9508198
    [Abstract] [Full Text] [Related]

  • 11. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study.
    Nasti G, Errante D, Talamini R, Rizzardini G, Fasan M, Landonio G, Zeroli C, Chichino G, Nigra E, Vaccher E, Tirelli U.
    J Clin Oncol; 2000 Apr 01; 18(7):1550-7. PubMed ID: 10735904
    [Abstract] [Full Text] [Related]

  • 12. Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
    Zhong DT, Shi CM, Chen Q, Huang JZ, Liang JG, Lin D.
    J Cancer Res Clin Oncol; 2012 Mar 01; 138(3):425-30. PubMed ID: 22160130
    [Abstract] [Full Text] [Related]

  • 13. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
    Harrison M, Tomlinson D, Stewart S.
    J Clin Oncol; 1995 Apr 01; 13(4):914-20. PubMed ID: 7707119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial.
    Olweny CL, Borok M, Gudza I, Clinch J, Cheang M, Kiire CF, Levy L, Otim-Oyet D, Nyamasve J, Schipper H.
    Int J Cancer; 2005 Feb 10; 113(4):632-9. PubMed ID: 15472910
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH.
    J Clin Oncol; 1998 Jul 10; 16(7):2445-51. PubMed ID: 9667262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.